|
Sign In to gain access to subscriptions and/or personal tools.
|
Paradoxical decrease in high-density lipoprotein-cholesterol associated with statin-fenofibrate combination therapy
Shirley Hulme
Shirley Hulme Diabetes Centre, Whiston Hospital Prescot, Merseyside, L34 5DR, UK
Sarah O'Brien
Janet Cardwell
Sid McNulty
Kevin Hardy
References
- J. Glaysher, C Van Heyningen. Paradoxical decrease in high-density lipoprotein-cholesterol associated with statin and fenofibrate combination therapy. Br J Diabetes Vasc Dis 2007;7:295-7.[Free Full Text]
- Marsh J., Hulme S., O'Brien S., McNulty S., Hardy K. Heterogeneous HDL-C response to fenofibrate therapy in diabetes. Diabetic Med 2004;21 (suppl2):A61.
The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 1,
5 (2008)
DOI: 10.1177/14746514080080010301

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G Magee and P C Sharpe
Paradoxical decreases in high-density lipoprotein cholesterol with fenofibrate: a quite common phenomenon
J. Clin. Pathol.,
March 1, 2009;
62(3):
250 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|